| Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy TT Ho, J Cadena, LM Childs, M Gonzalez-Velez, JS Lewis Journal of antimicrobial chemotherapy 67 (5), 1267-1270, 2012 | 151 | 2012 |
| Tedizolid: a new oxazolidinone antimicrobial JJ Kisgen, H Mansour, NR Unger, LM Childs American Journal of Health-System Pharmacy 71 (8), 621-633, 2014 | 90 | 2014 |
| Use of learning style frameworks in health science education L Childs-Kean, M Edwards, MD Smith American Journal of Pharmaceutical Education 84 (7), ajpe7885, 2020 | 74 | 2020 |
| Social media profiles: striking the right balance LM Childs, CY Martin American Journal of Health-System Pharmacy 69 (23), 2044-2050, 2012 | 57 | 2012 |
| The alteration of the gut microbiome by immunosuppressive agents used in solid organ transplantation CM Gibson, LM Childs‐Kean, Z Naziruddin, CK Howell Transplant Infectious Disease 23 (1), e13397, 2021 | 43 | 2021 |
| Simeprevir and sofosbuvir for treatment of chronic hepatitis C infection LM Childs-Kean, EO Hand Clinical therapeutics 37 (2), 243-267, 2015 | 41 | 2015 |
| Tenofovir Alafenamide for the Treatment of Chronic Hepatitis B Monoinfection LM Childs‐Kean, EF Egelund, J Jourjy Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38 (10 …, 2018 | 35 | 2018 |
| Aminoglycoside Allergic Reactions LM Childs-Kean, KM Shaeer, S Varghese Gupta, JC Cho Pharmacy 7 (3), 124, 2019 | 32 | 2019 |
| Elvitegravir for the treatment of HIV NR Unger, MV Worley, JJ Kisgen, EM Sherman, LM Childs-Kean Expert opinion on pharmacotherapy 17 (17), 2359-2370, 2016 | 29 | 2016 |
| Recent updates in antimicrobial stewardship in outpatient parenteral antimicrobial therapy MV Mahoney, LM Childs-Kean, P Khan, CG Rivera, RW Stevens, ... Current Infectious Disease Reports 23, 1-8, 2021 | 27 | 2021 |
| Relationship between pharmacy students’ use of self-regulated learning strategies and course outcomes SA Voils, LM Childs-Kean, A Thomas American Journal of Pharmaceutical Education 83 (10), 7566, 2019 | 22 | 2019 |
| Sofosbuvir/Velpatasvir/Voxilaprevir: A Pan-Genotypic Direct-Acting Antiviral Combination for Hepatitis C EB Chahine, D Kelley, LM Childs-Kean Annals of Pharmacotherapy 52 (4), 352-363, 2018 | 21 | 2018 |
| Contemporary Pharmacotherapies for Nontuberculosis Mycobacterial Infections: A Narrative Review TM Johnson, TF Byrd, WK Drummond, LM Childs-Kean, MV Mahoney, ... Infectious Diseases and Therapy 12 (2), 343-365, 2023 | 20 | 2023 |
| Stop tempting your students to cheat MZ Farland, LM Childs-Kean Currents in Pharmacy Teaching and Learning 13 (6), 588-590, 2021 | 19 | 2021 |
| Use of personality frameworks in health science education L Childs-Kean, M Edwards, MD Smith American Journal of Pharmaceutical Education 84 (8), ajpe7231, 2020 | 17 | 2020 |
| Cefazolin Versus Anti-Staphylococcal Penicillins for the Treatment of Patients with Methicillin-Susceptible Staphylococcus aureus Infection: A Meta-Analysis with … JM Allen, L Bakare, AM Casapao, K Klinker, LM Childs-Kean, ... Infectious Diseases and Therapy 8, 671-686, 2019 | 17 | 2019 |
| Profile of sofosbuvir/velpatasvir/voxilaprevir in the treatment of hepatitis C LM Childs-Kean, NA Brumwell, EF Lodl Infection and Drug Resistance, 2259-2268, 2019 | 17 | 2019 |
| Doing more with less: Review of dolutegravir-lamivudine, a novel single-tablet regimen for antiretroviral-Naïve adults with HIV-1 infection BA Santevecchi, S Miller, LM Childs-Kean Annals of Pharmacotherapy 54 (12), 1252-1259, 2020 | 12 | 2020 |
| The Impact of Direct‐Acting Antiviral Therapy on End‐Stage Liver Disease Among Individuals with Chronic Hepatitis C and Substance Use Disorders H Park, X Jiang, HJ Song, V Lo Re III, LM Childs‐Kean, WH Lo‐Ciganic, ... Hepatology 74 (2), 566-581, 2021 | 11 | 2021 |
| Return of the tetracyclines: Omadacycline, a novel aminomethylcycline antimicrobial JC Cho, LM Childs-Kean, MT Zmarlicka, MP Crotty Drugs of today (Barcelona, Spain: 1998) 54 (3), 209-217, 2018 | 10 | 2018 |
Stacy VoilsUniversity of FloridaVerified email at cop.ufl.edu
